Form 8-K - Current report:
SEC Accession No. 0000950103-25-005798
Filing Date
2025-05-07
Accepted
2025-05-07 07:15:48
Documents
16
Period of Report
2025-05-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp228602_8k.htm   iXBRL 8-K 37316
5 EXHIBIT 10.1 dp228602_ex1001.htm EX-10.1 91040
6 EXHIBIT 99.1 dp228602_ex9901.htm EX-99.1 23527
7 GRAPHIC image_001.jpg GRAPHIC 3647
  Complete submission text file 0000950103-25-005798.txt   364096

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE crl-20250507.xsd EX-101.SCH 2996
3 XBRL LABEL FILE crl-20250507_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE crl-20250507_pre.xml EX-101.PRE 22347
18 EXTRACTED XBRL INSTANCE DOCUMENT dp228602_8k_htm.xml XML 3575
Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887
Business Address 251 BALLARDVALE ST WILMINGTON MA 01887 781-222-6000
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (Filer) CIK: 0001100682 (see all company filings)

EIN.: 061397316 | Fiscal Year End: 1227
Type: 8-K | Act: 34 | File No.: 001-15943 | Film No.: 25919265
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)